Imatinib mesylate (STI571) therapy for Philadelphia chromosome-positive chronic myelogenous leukemia in blast phase

Hagop M. Kantarjian, Jorge Cortes, Susan O'Brien, Francis J. Giles, Maher Albitar, Mary Beth Rios, Jianqin Shan, Stefan Faderl, Guillermo Garcia-Manero, Deborah A. Thomas, Debra Resta, Moshe Talpaz

Research output: Contribution to journalArticlepeer-review

274 Scopus citations

Fingerprint

Dive into the research topics of 'Imatinib mesylate (STI571) therapy for Philadelphia chromosome-positive chronic myelogenous leukemia in blast phase'. Together they form a unique fingerprint.

Medicine & Life Sciences

Chemical Compounds